These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2785161)

  • 1. The contribution of mortality statistics to the study of multiple sclerosis in Australia.
    Hammond SR; English DR; de Wytt C; Hallpike JF; Millingen KS; Stewart-Wynne EG; McLeod JG; McCall MG
    J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):1-7. PubMed ID: 2785161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of multiple sclerosis in Queensland, Australia.
    Hammond SR; de Wytt C; Maxwell IC; Landy PJ; English D; McLeod JG; McCall MG
    J Neurol Sci; 1987 Sep; 80(2-3):185-204. PubMed ID: 3681330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
    Hammond SR; English DR; McLeod JG
    Brain; 2000 May; 123 ( Pt 5)():968-74. PubMed ID: 10775541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.
    Hammond SR; McLeod JG; Millingen KS; Stewart-Wynne EG; English D; Holland JT; McCall MG
    Brain; 1988 Feb; 111 ( Pt 1)():1-25. PubMed ID: 3365543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
    McLeod JG; Hammond SR; Hallpike JF
    Med J Aust; 1994 Feb; 160(3):117-22. PubMed ID: 8295576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales.
    Dean G; Elian M
    J Neurol Neurosurg Psychiatry; 1993 Jun; 56(6):633-7. PubMed ID: 8509776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality rates from multiple sclerosis: geographical and temporal variations revisited.
    Williams ES; Jones DR; McKeran RO
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):104-9. PubMed ID: 2019834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?
    Miller DH; Hammond SR; McLeod JG; Purdie G; Skegg DC
    J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):903-5. PubMed ID: 2266373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration and multiple sclerosis in immigrants from United Kingdom and Ireland to Australia: a reassessment. III: risk of multiple sclerosis in UKI immigrants and Australian-born in Hobart, Tasmania.
    Barnett MH; McLeod JG; Hammond SR; Kurtzke JF
    J Neurol; 2016 Apr; 263(4):792-8. PubMed ID: 26914927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity and mortality in motor neuron disease: comparison with multiple sclerosis and Parkinson's disease: age and sex specific rates and cohort analyses.
    Li TM; Swash M; Alberman E
    J Neurol Neurosurg Psychiatry; 1985 Apr; 48(4):320-7. PubMed ID: 3873517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: a reassessment. I. Risk of MS by age at immigration.
    McLeod JG; Hammond SR; Kurtzke JF
    J Neurol; 2011 Jun; 258(6):1140-9. PubMed ID: 21264474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mortality rates for multiple sclerosis in Italy (1969-1987).
    Meco G; Vanacore N; Bonifati V
    Neuroepidemiology; 1994; 13(4):162-74. PubMed ID: 8090258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study.
    Esparza ML; Sasaki S; Kesteloot H
    Am J Epidemiol; 1995 Oct; 142(7):733-7. PubMed ID: 7572944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
    Hollingworth S; Walker K; Page A; Eadie M
    Mult Scler; 2013 Nov; 19(13):1712-6. PubMed ID: 23530000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis and prostate cancer: what do their similar geographies suggest?
    Schwartz GG
    Neuroepidemiology; 1992; 11(4-6):244-54. PubMed ID: 1291888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World-wide trends in multiple sclerosis mortality.
    Lai SM; Zhang ZX; Alter M; Sobel E
    Neuroepidemiology; 1989; 8(2):56-67. PubMed ID: 2922099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution of multiple sclerosis in the United Kingdom.
    Swingler RJ; Compston D
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1115-24. PubMed ID: 3783172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The latitude gradient for multiple sclerosis prevalence is established in the early life course.
    Sabel CE; Pearson JF; Mason DF; Willoughby E; Abernethy DA; Taylor BV
    Brain; 2021 Aug; 144(7):2038-2046. PubMed ID: 33704407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method for calculating prevalence of multiple sclerosis in Australia.
    Palmer AJ; Hitchens PL; Simpson S; O'Leary B; Colman S; Taylor BV
    Mult Scler; 2013 Nov; 19(13):1704-11. PubMed ID: 23587604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of multiple sclerosis in the Leeds Health Authority.
    Ford HL; Gerry E; Airey CM; Vail A; Johnson MH; Williams DR
    J Neurol Neurosurg Psychiatry; 1998 May; 64(5):605-10. PubMed ID: 9598675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.